IGMS: IGM Biosciences, Inc. Stock

by  •  • Comments Off on IGMS: IGM Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 58.27
Enterprise Value ($M) 15.40
Book Value ($M) 78.95
Book Value / Share 2.32
Price / Book 0.74
NCAV ($M) 4.07
NCAV / Share 0.12
Price / NCAV 14.32

Profitability (mra)
Return on Invested Capital (ROIC) -1.76
Return on Assets (ROA) -0.52
Return on Equity (ROE) -1.08

Liquidity (mrq)
Quick Ratio 5.22
Current Ratio 5.22

Balance Sheet (mrq) ($M)
Current Assets 229.63
Assets 304.51
Liabilities 225.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Price T Rowe Associates Inc /md/ 11.80 17.94
11-12 13G/A Fmr Llc 2.42 -51.75
08-02 13G/A Invus Global Management, LLC 9.90
03-28 13D/A Baker Bros. Advisors Lp 12.40 10.71
02-09 13G/A Artal International S.C.A. 9.40 26.55

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-07 10-K Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 242,357 2,692,039 9.00
2025-01-14 159,785 758,351 21.07
2025-01-13 279,122 1,369,124 20.39
2025-01-10 994,711 4,842,427 20.54

(click for more detail)

Similar Companies
IDXX – IDEXX Laboratories, Inc. IDYA – IDEAYA Biosciences, Inc.
IFRX – InflaRx N.V. IMUX – Immunic, Inc.
IMVT – Immunovant, Inc.


Financial data and stock pages provided by
Fintel.io